Wang J, Pejaver VR, Dann GP, et al. Target site specificity and in vivo complexity of the mammalian arginylome. Sci Rep. 2018;8(1):16177. doi:10.1038/s41598-018-34639-6
Yu E, Ruiz-Canela M, Razquin C, et al. Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial. Diabetes Obes Metab. 2019;21(2):397-401. doi:10.1111/dom.13514
Stražar M, Temba GS, Vlamakis H, et al. Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations. Nat Commun. 2021;12(1):4845. doi:10.1038/s41467-021-25213-2
Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science. 1994;266(5188):1241-7.
Raisner RM, Hartley PD, Meneghini MD, et al. Histone variant H2A.Z marks the 5’ ends of both active and inactive genes in euchromatin. Cell. 2005;123(2):233-48. doi:10.1016/j.cell.2005.10.002
Weiss GA, Valentekovich RJ, Collins EJ, et al. Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine. Proc Natl Acad Sci U S A. 1996;93(20):10945-8.
Weng Z, Rickles RJ, Feng S, et al. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol. 1995;15(10):5627-34.
Yu E, Ruiz-Canela M, Hu FB, et al. Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study. J Clin Endocrinol Metab. 2017;102(6):1879-1888. doi:10.1210/jc.2016-3569
Scally SW, Law SC, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017;76(11):1915-1923. doi:10.1136/annrheumdis-2017-211300
Zaytouni T, Tsai PY, Hitchcock DS, et al. Critical role for arginase 2 in obesity-associated pancreatic cancer. Nat Commun. 2017;8(1):242. doi:10.1038/s41467-017-00331-y